Renal Cell Carcinoma: Incidence and Cost Estimation in the Era of Targeted Therapy

Bosetti C. , Bianchi C. , Negri E. , La Vecchia C. : Estimates of the incidence and prevalence of renal cell carcinoma in Italy in 2002 and projections for the years 2007 and 2012. Tumori, 95: 142–145, 2009.

Meropol N.J. , Schrag D. , Smith T.J. , Mulvey T.M. , Langdon R.M. Jr. , Blum D. , Ubel P.A. , Schnipper L.E. ; American Society of Clinical Oncology: American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol, 27: 3868–3874, 2009.

Agenzia Italiana del Farmaco AIFA: Registro farmaci oncologici sottoposti a monitoraggio. Rapporto Nazionale 2007. Available at http://antineoplastici.agenziafarmaco.it/rap-porto_RFOM_2007.htm

Ries L.A.G. , Eisner M.P. , Kosary C.L. , Hankey B.F. , Miller B.A. , Clegg L. , Mariotto A. , Feuer E.J. , Edwards BK (Eds): SEER Cancer Statistics Review, 1975–2002, National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2002/ (accessed April 2010) based on November 2004 SEER data submission, posted to the SEER web site 2005.